ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
flyer100
|
37 |
14K |
0 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
37
|
14K
|
0
|
|
ASX - By Stock
|
QPM |
Re:
Ann: Acquisition of Moranbah Project
|
|
flyer100
|
166 |
58K |
5 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
166
|
58K
|
5
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
flyer100
|
3.3K |
969K |
26 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
3.3K
|
969K
|
26
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
flyer100
|
37 |
14K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
37
|
14K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
flyer100
|
37 |
14K |
0 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
37
|
14K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Looking forward
|
|
flyer100
|
10 |
5.8K |
2 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
10
|
5.8K
|
2
|
|
ASX - By Stock
|
QPM |
Re:
Ann: German Supplier Collaboration and ECA Funding
|
|
flyer100
|
112 |
42K |
16 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
112
|
42K
|
16
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change in substantial holding
|
|
flyer100
|
25 |
10K |
5 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
25
|
10K
|
5
|
|
ASX - By Stock
|
QPM |
Re:
Ann: Significant Investment Project Status
|
|
flyer100
|
49 |
21K |
19 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
49
|
21K
|
19
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
flyer100
|
33 |
16K |
4 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
33
|
16K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
flyer100
|
33 |
16K |
0 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
33
|
16K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
flyer100
|
33 |
16K |
7 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
33
|
16K
|
7
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
flyer100
|
61 |
32K |
10 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
61
|
32K
|
10
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
flyer100
|
61 |
32K |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
61
|
32K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Pause in Trading
|
|
flyer100
|
10 |
4.0K |
2 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
10
|
4.0K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma to restate US dermatology net revenue for FY22
|
|
flyer100
|
46 |
19K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
46
|
19K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Some Analysis
|
|
flyer100
|
78 |
32K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
78
|
32K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
flyer100
|
98 |
47K |
4 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
98
|
47K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
flyer100
|
98 |
47K |
5 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
98
|
47K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
flyer100
|
44 |
20K |
7 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
44
|
20K
|
7
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
flyer100
|
197 |
75K |
2 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
197
|
75K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
flyer100
|
197 |
75K |
2 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
197
|
75K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
flyer100
|
197 |
75K |
9 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
75K
|
9
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
flyer100
|
197 |
75K |
9 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
75K
|
9
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
flyer100
|
197 |
75K |
5 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
197
|
75K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
takeover target
|
|
flyer100
|
40 |
21K |
7 |
05/11/22 |
05/11/22 |
ASX - By Stock
|
40
|
21K
|
7
|
|
ASX - By Stock
|
MYX |
Re:
takeover target
|
|
flyer100
|
40 |
21K |
1 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
40
|
21K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
IS SHARE CONSOLIDATION SIGNALLING SOME THING BIG?
|
|
flyer100
|
72 |
31K |
3 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
72
|
31K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
IS SHARE CONSOLIDATION SIGNALLING SOME THING BIG?
|
|
flyer100
|
72 |
31K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
72
|
31K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma capital management update
|
|
flyer100
|
61 |
26K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
61
|
26K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Annual Report to shareholders
|
|
flyer100
|
51 |
19K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
51
|
19K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Annual Report to shareholders
|
|
flyer100
|
51 |
19K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
51
|
19K
|
2
|
|
ASX - By Stock
|
MYX |
Mithra’s Donesta phase 3 trial results
|
|
flyer100
|
2 |
1.6K |
0 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
2
|
1.6K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Annual Report to shareholders
|
|
flyer100
|
51 |
19K |
1 |
15/10/22 |
15/10/22 |
ASX - By Stock
|
51
|
19K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Annual Report to shareholders
|
|
flyer100
|
51 |
19K |
1 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
51
|
19K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma completes sale of Metrics Contract Services
|
|
flyer100
|
82 |
34K |
6 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
82
|
34K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma completes sale of Metrics Contract Services
|
|
flyer100
|
82 |
34K |
4 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
82
|
34K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
New Mayne Pharma CEO Starts Today
|
|
flyer100
|
5 |
2.7K |
3 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
5
|
2.7K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma appoints new CEO
|
|
flyer100
|
19 |
7.9K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
19
|
7.9K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma appoints new CEO
|
|
flyer100
|
19 |
7.9K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
19
|
7.9K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Non-Executive Director appointment and retirement
|
|
flyer100
|
19 |
10K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
19
|
10K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Non-Executive Director appointment and retirement
|
|
flyer100
|
19 |
10K |
2 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
19
|
10K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Suggestion for MYX mgt
|
|
flyer100
|
3 |
1.6K |
0 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
flyer100
|
88 |
40K |
0 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
88
|
40K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
flyer100
|
88 |
40K |
3 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
88
|
40K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
flyer100
|
88 |
40K |
10 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
88
|
40K
|
10
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
flyer100
|
88 |
40K |
1 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
88
|
40K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
flyer100
|
537 |
244K |
1 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
537
|
244K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
flyer100
|
537 |
244K |
2 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
537
|
244K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
flyer100
|
88 |
40K |
0 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
88
|
40K
|
0
|
|